How East Ocyon Bio is building an off-the-shelf cancer cell therapy in Gurugram

The Gurugram-based company is developing allogeneic CAR-NK cell therapies made from healthy donor cells, backed by a $4.2 million seed round and a government grant covering both resistant tumours and leishmaniasis.

Raccontata dayourstory.com